Services to perform IGF-1 and igfbp-3 elisa assays on serum collected from 315 participants in the KTB study in order to assess whether IGF-1, igfbp-3, and the ratio of IGF-1/igfbp-3 are related to…
Ended Purchase Order Awarded
- Contract number
- HHSN261201500248P
- Awardee
-
The Sir Mortimer B. Davis-Jewish General Hospital UEI EMCNUAEK3UV3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,640
Award facts
- Contract value 100% obligated
- $17,640.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Canada
Award details come from SAM.gov/FPDS.
Description
Services to perform IGF-1 and igfbp-3 elisa assays on serum collected from 315 participants in the KTB study in order to assess whether IGF-1, igfbp-3, and the ratio of IGF-1/igfbp-3 are related to tdlu involution in both african americans and caucasians.
Quick answers
Who was awarded contract HHSN261201500248P?
HHSN261201500248P was awarded to The Sir Mortimer B. Davis-Jewish General Hospital by National Cancer Institute (National Institutes of Health) on September 22, 2015.
How much is contract HHSN261201500248P worth?
The government has obligated $17,640 on HHSN261201500248P.
Was contract HHSN261201500248P competed?
The extent of competition for HHSN261201500248P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award